Which one of the following does NOT act by increasing insulin secretion
**Core Concept**
The regulation of insulin secretion is crucial for glucose homeostasis. Insulin secretion is primarily regulated by the pancreatic beta cells, which release insulin in response to elevated blood glucose levels. Various pharmacological agents can modulate insulin secretion, either by stimulating or inhibiting its release.
**Why the Correct Answer is Right**
The correct answer is the one that does NOT increase insulin secretion. Insulin secretion is typically increased by agents that stimulate the pancreatic beta cells, such as sulfonylureas, meglitinides, and incretin mimetics. These agents work by binding to specific receptors on the beta cells, leading to an increase in insulin secretion. For example, sulfonylureas bind to the SUR1 receptor, which closes potassium channels and depolarizes the beta cells, leading to an influx of calcium ions and insulin release.
**Why Each Wrong Option is Incorrect**
**Option A:** Sulfonylureas, such as glipizide, work by increasing insulin secretion, making this option incorrect.
**Option B:** Meglitinides, such as repaglinide, also increase insulin secretion by stimulating the pancreatic beta cells, making this option incorrect.
**Option C:** Exenatide, an incretin mimetic, increases insulin secretion by enhancing the release of insulin from the pancreatic beta cells in response to glucose, making this option incorrect.
**Clinical Pearl / High-Yield Fact**
It's essential to remember that sulfonylureas can cause hypoglycemia due to their ability to stimulate insulin secretion, especially in patients with renal impairment.
**Correct Answer:** D.